> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 18-Page FDA-483 on Ipca Laboratories Inspection
- URL: https://www.fdaweb.com/18-page-fda-483-on-ipca-laboratories-inspection/
- Published: 2023-06-29T12:00:00.000Z
- Updated: 2026-09-14T18:41:55.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5154801

FDA has released an 18-page form FDA-483 with 11 observations from a 6/5-6/13 inspection at Ipca Laboratories, an active pharmaceutical ingredient (API) manufacturer in Ratlam, Madhya Pradesh, India. The [observations](https://www.fda.gov/media/169917/download?ref=fdaweb.com) were:

- investigations are inadequate to determine the root cause for the failure of a batch of intermediate or API to meet specifications, whether or not the batch has already been distributed;
- the quality unit failed to take adequate actions against the failing API batches being sold in the domestic and international markets;
- the reworked API is not subjected to appropriate evaluation, testing, stability testing if warranted, and documentation to show that the reworked product is of equivalent quality to that produced by the original process;
- failing to establish an optimal processing condition that ensures consistency in critical quality attributes of the APIs;
- failing to oversee and exercise control over the manufacture of drugs to ensure quality, including managing the risk of and establishing the safety of materials used in the manufacturing of drugs;
- failing to ensure that all specifications and test procedures are scientifically sound and appropriate to ensure that raw materials and API conform to established standards of quality;
- laboratory tests to determine conformance to specification for each batch of intermediate and API are deficient;
- the quality unit failed to ensure all deviations are reported on the batch certificate and certified by the third-party consultants;
- calibration of the laboratory equipment used in the Micro Lab is deficient;
- the determination made to establish the suitability of a secondary reference standard by comparing it against the primary reference standard is deficient; and
- failing to maintain complete records of major equipment use, cleaning, and maintenance.